Drugs that contain Aliskiren Hemifumarate; Hydrochlorothiazide
1. Tekturna Hct patents expiration
TEKTURNA HCT's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9023893 | NODEN PHARMA | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
Mar, 2022
(1 year, 8 months ago) | |
| US8618172 | NODEN PHARMA | Galenical formulations of organic compounds |
Jul, 2028
(4 years from now) | |
Market Authorisation Date: 18 January, 2008
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of TEKTURNA HCT before it's drug patent expiration?
More Information on Dosage
TEKTURNA HCT family patents
